Published in Obesity and Diabetes Week, June 19th, 2006
According to recent research from Ghana, "We have investigated the role of haptoglobin gene polymorphisms in 129 type 2 diabetic patients and 87 nondiabetic subjects, classified by the ADA criteria, in Ghana. The diabetic subjects were recruited consecutively from the National Diabetic Management and Research Center of the University of Ghana Medical School, Korle-Bu, Accra, Ghana and were categorized by their haptoglobin phenotypes."
I.K. Quaye and colleagues at the University of Ghana discovered, "The haptoglobin 2 allele was determined to be a risk factor for type 2 diabetes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.